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Abstract
Background: The nonspecific clinical presentation and paucibacillary nature of tuberculous pleuritis remains a challenge for
diagnosis. Diagnosis of tuberculous pleural effusion depends on the demonstration of the presence of tubercle bacilli in the
sputum, pleural fluid, or pleural biopsy specimen, or demonstration of granuloma in pleura by histological examination. We
examined the clinical utility of the diagnosis of pleural tuberculosis using the in house N-PCR assay, AFB smear microscopy
and culture. Besides pleural fluid the inclusion of sputum in the efficacy of diagnosis of pleural tuberculosis was scrutinized.
Methodology/Principal Findings: Pleural fluid and sputum samples of 58 tuberculous and 42 non-tuberculous pleural
effusion patients were processed for AFB smear microscopy, culture and the N-PCR assay. Mycobacteria were detected
exclusively in tuberculous pleural effusion samples. None of the non-tuberculous pleural effusion samples were positive for
mycobacteria. Comparative analysis showed that the N-PCR assay had the highest sensitivity. Inclusion of sputum along
with pleural fluid increased N-PCR sensitivity from 51.7 to 70.6% (p,0.0001).This improved sensitivity was reflected in AFB
smear microscopy and isolation by culture. The sensitivity enhanced on inclusion of sputum from 3.4 (p=0.50) to 10.3%
(p=0.038) for AFB smear microscopy and for isolation of mycobacteria from 10.3(p=0.03) to 22.4% (p=0.0005). Thirteen
isolates were obtained from 58 pleural tuberculosis patients. Eleven mycobacterial isolates were identified as M.tuberculosis
and two as M.fortuitum and M.chelonae. Complete concordance was seen between the biochemical identification of isolates
and the N-PCR identification of mycobacterial species prior to isolation.
Conclusions/Significance: To the best of our knowledge this is the first PCR based report on utility of sputum for diagnosis
of pleural tuberculosis. The present study demonstrates that a combination of pleural fluid with sputum sample and N-PCR
improved the diagnosis of pleural tuberculosis.
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Introduction
Pleural Tuberculosis is a common manifestation of extra
pulmonary tuberculosis and is a frequent cause of pleural effusion
[1–2]. Tuberculous pleural effusion (TPE) occurs in up to 30% of
tuberculosis patients [3]. Its occurrence in developing countries
has increased following the HIV pandemic [4].
Rapid diagnosis and administration of prompt anti-tuberculous
treatment of pleural tuberculosis is needed to reverse the morbidity
due to tuberculosis (TB). Owing to the paucibacillary nature of the
pleural fluid, the diagnosis of tuberculous pleuritis is a challenge
[5]. Hence in addition to collection of pleural fluid in suspected
cases of Tuberculous pleural effusion, it has been recommended
that sputum be included for laboratory investigation as an
additional sample, [6–7]. To improve the detection of mycobac-
terial pathogens in paucibacillary samples inclusion of sensitive
probes such as molecular beacons would be an added advantage,
[8]. The definitive diagnosis of pleural tuberculosis is currently
made by demonstrating the presence of tubercle bacilli in
specimens such as sputum/pleural fluid and/pleural biopsies, or
by histological examination of pleural tissue for granulomas [4]. As
these methods are disadvantaged by the sensitivity and time
required for detection and identification of mycobacterial
pathogens in clinical samples, in the present study, we examined
the potential of DNA amplification techniques to rapidly detect
Mycobacterium tuberculosis/Mycobacterium bovis in pleural fluid. Besides
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10220pleural fluid the clinical utility of inclusion of sputum for diagnosis
of pleural tuberculosis was also examined. N-PCR targeting the
hupB gene (Rv2986c) was used to detect Mycobacterium tuberculosis
(Mtb) and Mycobacterium bovis (Mbo) in pleural fluid and sputum
samples collected in tandem from pleural effusion patients. The
utility of the assay in the detection of mycobacterial pathogens
namely Mtb and Mbo in clinical samples has been previously
reported [9–10]. The results obtained using the N-PCR assay was
compared with Acid Fast Bacilli (AFB) microscopy and isolation
and identification of AFB by culture present in pleural fluid and
sputum derived from pleural effusion patients.
Materials and Methods
Patient’s selection & study design
Ethics Statement:. The study, information sheet and
consent form used was approved by the institutional ethical
committees of the All India Institute of Medical Sciences, New
Delhi & Vardhaman Mahavir Medical College & Safdarjung
Hospital, New Delhi-110029. India. Informed written consent
from all participants involved in our study has been obtained.
Over a 4 year period, 100 pleural effusion patients with no
history of anti-tuberculosis treatment registered in the Department
of Respiratory Medicine, Safdarjung Hospital, New Delhi were
included in the study. Pleural fluid was aseptically aspirated under
sterile conditions in the minor procedure room facility and
transported to the laboratory for investigation. The clinical
diagnosis was not available during the laboratory investigation.
The diagnosis was available during data analysis.
All the patients included in the study were patients with pleural
effusion and did not have lung parenchymal involvement. The
clinical criteria as described by Light (2001) [11] were adopted for
the diagnosis of pleural tuberculosis. The definitive/confirmed
criterion for tuberculous pleural effusion was the demonstration of
AFB in pleural fluid and or sputum by microscopy or culture.
Suggestive/probable criteria included:(1) patients with clinical
history of fever, pleuritic chest pain, cough, breathlessness, and
chest radiography for evidence of pleural effusion; (2) cytological
examination of the pleural fluid for predominance of lymphocytes,
paucity of mesothelial cells;(3) biochemical estimation for protein
content (.3 gm per dl) and pleural fluid: serum protein ratio
(.0.5); and (4) response of patients to anti-tuberculous treatment.
Tuberculous pleural effusion was diagnosed if the definitive
criterion or all of the suggestive criteria were met. Based on these
criteria 58 patients were classified as patients with tuberculous
pleural effusion. Sputum as well as pleural fluid was collected from
all of them and investigated, [6–7].
Criteria used for malignant pleural effusion (controls) were: (i)
Clinical history suggestive of rapidly refilling pleural effusion; with
or without focal malignant lesion elsewhere in the body. (ii) Pleural
fluid being exudative, usually hemorrhagic and (iii) on cytological
examination positive for malignant cells. Based on these criteria 42
patients were classified as non-tuberculous pleural effusion patients
(N-TPE). In twelve of these patients sputum was collected in
addition to the pleural fluid.
Sample Processing
For isolation of mycobacteria:. All the clinical samples
were processed in Biosafty level 3 (BSL-3) facility. After collection,
samples were transported at 4–8uC and held at this temperature in
the facility till they were processed for isolation & DNA extraction.
All samples were processed with in 24 hours of collection with
freshly prepared reagents. Only 2–3 clinical samples were
processed at a time to minimize sample cross contamination by
trained personnel.
Pleural fluid:. 100 pleural fluid samples were processed by
NALC-NaOH method [12]. In brief, pleural fluid was centrifuged
at 4,500 g for 15 min. The pellet was treated with an equal
volume of N-acetyl-L-cysteine- NaOH (NALC-NaOH; NaOH
final concentration, 2%) for 15 min at room temperature and
neutralized with sterile phosphate buffer (0.067 M, pH 6.8). After
centrifugation at 4,500 g for 15 min, the pellet was resuspended in
1 ml of sterile distilled water [13]. The suspension was divided into
two parts. One part was used for AFB smear microscopy and as
inoculums for isolation of AFB by culture on Lowenstein Jensen
media & 7H9 or in MGIT tubes (BD BACTEC MGIT 960
system). The second part was used for DNA extraction. Sputum
collected from 70 patients was similarly processed.
Ziehl-Neelsen smear of pleural fluid & sputum:. Ziehl-
Neelsen acid fast staining was used to confirm the presence of
AFB.
Pleural fluid and sputum culture:. As described processed
clinical specimens (Pleural fluid & sputum) obtained from 69
pleural effusion patients were inoculated on LJ slants & 7H9 liquid
media and were incubated at 37uC for 8 weeks. LJ slants were
inspected twice a week for visible colonies, and were screened for
AFB by ZN staining. The liquid media were examined at identical
time points for growth. Tubes showing visible growth were
screened for AFB by ZN staining. Positive liquid cultures were sub-
cultured on to LJ media for isolation of mycobacteria. Following
the access to the automated system concentrated clinical
specimens (0.5 ml) obtained from 31 pleural effusion patients
were inoculated in the MGIT media alone containing PANTA
antibiotics mixture as per manufacturers’ recommendation and
monitored continuously in MGIT 960 system (BD BACTEC
TM
MGIT
TM 960 system for mycobacteria testing, USA).
Identification of mycobacteria isolated from pleural fluid
and sputum. Species level identification of the isolates was done
by standard biochemical tests (niacin production, nitrate
reduction, catalase and aryl sulfatase activity, Tween hydrolysis,
thiopen-2-carboxylic acid hydrazide sensitivity, etc.) as recom-
mended by the Centers for Disease Control and Prevention
(CDC), Atlanta, Ga., with appropriate controls [14]. For this part
of the study mycobacterial colonies derived from LJ media were
used.
Extraction of template DNA
Positive Control template DNA:. Mtb H37Rv & Mbo AN5
colonies suspended in 100 ml of 0.1% triton X-100 was boiled in a
dry bath (90uC for 40 mins.), centrifuged (10,000 g, for 10 min.)
and the supernate was aliquoted & stored at 220uC. The
supernatant was used as target DNA in the PCR assay. Mtb
H37Rv & Mbo AN5 strains were obtained from National JALMA
Institute for leprosy & other mycobacterial Diseases (ICMR),
Agra, India. Besides Mtb cultures Mycobacterium tuberculosis H37Rv
DNA obtained from ‘‘TB research Materials and Vaccine
Testing’’ was also used as a control.
Template DNA from clinical samples:. The 2
nd portion of the
suspension obtained from the processed clinical samples was
centrifuged. The pellet was suspended in 100 ml of 0.1% triton X-
100 & boiled in a dry bath, (90uC for 40 mins.). The suspension
was centrifuged and processed as described for DNA extraction for
positive control template DNA.
Nested PCR for hupB DNA target (International patent
application no. PCT/IN03/00302):. The details of the assay
have been described previously [10]. The primers N (59-
GAGGGTTGGGATGAACAAAGCAG-39) and S (59-TATC-
Improved Pleural TB Diagnosis
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gene. The amplified N-S PCR product was used as a template
for the N-PCR. The primer pair for the N-PCR F (59-CCA-
AGAAGGCGACAAAGG-39) and R (59-GACAGCTTTCTT-
GGCGGG-39) was used. The N-PCR products were electro-
phoresed on 10% polyacrylamide gel and stained with ethidium
bromide. The amplicon size for Mtb and Mbo was ,116 bp and
89 bp respectively [15]. For the N-PCR assay, the following
controls were routinely included: negative control (with out
template DNA) was incorporated in the assay to rule out the
occurrence of false-positives. Spiked controls were included to rule
out the occurrence of false-negative results in the study due to the
presence of PCR inhibitors in DNA extracts of samples. Beside
these two controls positive control with target DNA was included
in each assay, [10].
Statistical Analysis:. All statistical analyses were done using
STATA software, version 9.2 (StataCorp, College Station, TX).
For all analyses, p values less than 0.05 were considered to indicate
statistical significance.
Results
The gender and age distribution of 100 pleural effusion patients
collected were as follows: 35 females and 65 males with a mean
age of 4268.8 and 4064.3 respectively. Based on clinical criteria
described 58 patients were categorized as TPE and the remaining
as N-TPE. AFB was detected by smear microscopy and or by
culture in 16 samples (sputum &/pleural fluid) derived from TPE
patients. These individuals were considered to be definitive/
confirmed cases of pleural TB (16/58, 27.5%). The remaining 42
in the TPE category were considered as probable cases of pleural
TB, (42/58, 72.4%). The N-PCR results were compared with: (i)
clinical diagnosis; (ii) improvement in the detection of mycobac-
teria in sputum samples besides pleural fluid; (iii) patients
segregated as AFB positive (confirmed TB pleurisy) Vs AFB
negative (probable TB pleurisy); and (iv) biochemical character-
ization of AFB isolates.
Detection of mycobacteria in pleural fluid samples
N-PCR, culture and AFB smear microscopy were compared
and have been shown in Table 1. In 31 samples, mycobacteria
were detected either by N-PCR/culture/AFB smear microscopy.
These 31 samples were derived from the 58 clinically diagnosed
tuberculous pleural effusion patients (TPE). In contrast, no
mycobacteria were detected in the 42 samples obtained from
non-tuberculous pleural effusion patients (N-TPE, controls).
By N-PCR assay 51.7% (30/58) of the pleural fluid samples
derived from TPE were positive for Mtb compared to 10.3% (6/
58) by culture & 3.4% (2/58) by AFB smear microscopy. In the
pleural fluid sample negative by the N-PCR assay, the AFB
isolated from the sample was subsequently identified as Mycobac-
terium fortuitum (Sample No. SPF-8). The six isolates were obtained,
two each from LJ, 7H9 & MGIT tubes respectively. All the assays
showed identical specificity & positive predictive value (PPV) but
differed in their sensitivity & negative predictive value (NPV). N-
PCR assay showed the highest sensitivity (51.7%) compared to
culture (10.3%) and AFB smear microscopy (3.4%, Table 1).
Detection of mycobacteria in sputum samples collected
from pleural effusion patients
Based on criteria described in methods the distribution of the 70
sputum samples collected from pleural effusion patients is shown in
Table 2. Fifty-eight sputum samples were from patients with
tuberculous pleural effusion and 12 were with non-tuberculous
pleural effusion. Identical methods were used for detecting Mtb in
these sputum samples as described earlier. Of the 70 samples
analyzed, in 33 samples Mycobacteria was detected either by N-
PCR/Culture/AFB smear microscopy. All the 33 positive samples
were derived from TPE. The twelve samples collected from N-
TPE were negative.
Using the N-PCR assay, 53.4% (31/58) of the sputum samples
were positive for mycobacteria compared to 12.1% (7/58) by
culture and 6.9% (4/58) by AFB smear microscopy. The seven
isolates were obtained, two each from LJ, 7H9 & three from
MGIT tubes respectively. Of the 33 samples in which mycobacteria
were detected, two of the samples were negative by the N-PCR
assay. In one sample, the AFB isolated was identified as
Mycobacterium chelonae (Sample No. SPF-80).The second sample
was AFB positive but culture and N-PCR negative (Sample
No. SPF-18). As seen earlier, the three methods used for detection
of mycobacteria in the sputum samples showed similar range of
specificity, PPV and sensitivity. All three methods showed 100%
specificity & PPV and their sensitivity was 53.4% by the N-PCR
assay, 12.1% by culture and 6.9% by AFB smear microscopy.
Comparison of N-PCR results with detection of AFB & its
isolation by culture in pleural fluid & sputum samples
AFB detection in smears and isolation of mycobacteria
enhanced, on inclusion of sputum samples besides pleural fluid
from clinically diagnosed cases of TPE, (Table 3). In case of
culture the isolation of mycobacteria was limited to 6 (10.3%)
Table 1. Comparative analysis of 100 Pleural fluid samples with N-PCR, Culture and AFB with clinical diagnosis.
Method Clinical diagnosis Sensitivity (%) Specificity & PPV (%) NPV (%) p value
Patients (58) Controls (42)
N-PCR Positive 30 0 51.7 100 60 p,0.0001
Negative 28 42
Culture Positive 6 0 10.3 100 44.6 p=0.038
Negative 52 42
AFB Positive 2 0 3.4 100 42.8 p=0.50
Negative 56 42
NOTE. Clinical diagnosis, Categorization of patients and controls as describe in methods; PPV, positive predictive value; NPV, negative predictive value; Sensitivity, TP/
(TP+ FN) x 100, where T is true, F is false, P is positive, and N is negative; Specificity, TN/(TN+ FP) x 100; N-PCR, 116 bp amplicon generated by Nested-PCR assay specific
for Mycobacterium tuberculosis; Culture, AFB Growth detected on LJ, 7H9 and/MGIT; AFB, acid fast bacilli.
doi:10.1371/journal.pone.0010220.t001
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collected in tandem from these TPE patients, mycobacteria were
isolated from an additional 7 sputum samples. No mycobacteria
were isolated from the pleural fluid samples of these 7 patients,
thereby improving the detection of mycobacteria with the
inclusion of sputum samples in this category of patients from 6
to 13 (22.4%, p=0.0005). In case of AFB smear microscopy the
number of positive samples increased from 2 (3.4%) to 6 (10.3%,
p=0.038, Table 3), with the detection of AFB in 4 sputum
samples, whereas the tandem pleural fluid samples of these
patients were AFB negative. Similarly, improved detection of
mycobacteria by the N-PCR assay in clinically diagnosed patients
of TPE increased on inclusion of sputum samples to that observed
by AFB smear microscopy and isolation by culture. By N-PCR in
30 pleural fluid samples Mtb was detected. On inclusion of sputum
for detection of Mtb from these patients, Mtb was detected in 11
sputum samples; the concomitant N-PCR results of the pleural
fluids derived from these 11 patients were negative by N-PCR.
The sensitivity of the detection of Mtb by N-PCR assay on
inclusion of sputum along with pleural fluid, in TPE patients
enhanced from 30 (51.7%, Table 1, 3) to 41 patients (70.6%,
p,0.0001, Table 3). Comparing the 3 methods for detection of
mycobacteria in the clinical samples, the highest sensitivity was
seen in case of N-PCR (70.6%), followed by culture (22.4%) and
the least by AFB smear microscopy, (10.3%).
Comparison of N-PCR assay results of AFB positive Vs
AFB Negative pleural fluid samples
Ten of the 16 (62.5%) and 20 of the 42 (47.6%) pleural fluid
samples were positive by the N-PCR assay derived from confirmed
& probable tuberculous pleural effusion patients (Table 4).
Inclusion of sputum samples enhanced the number of positive
cases in both category of patients. In case of confirmed AFB
positive cases of pleural TB, the detection of Mtb by N-PCR
increased from 10 to 14 patients. Similarly in case of AFB negative
cases but clinically diagnosed as pleural TB, the detection of Mtb
increased from 20 to 27 patients. Inclusion of sputum enhanced
the sensitivity of Mtb detection by N-PCR assay in confirmed (62.5
to 87.5%) and as well as in probable but AFB negative cases (47.6
to 64.2%) of pleural TB. By the N-PCR assay distinction between
confirmed and clinically suspected cases of pleural TB was not
feasible.
Correlation of Direct detection of Mycobacteria in clinical
samples by N-PCR assay Vs biochemical identification of
isolates
The results of the N-PCR assay, AFB smear microscopy,
isolation by culture and biochemical identification of the isolates
has been detailed in Table 5. In all 13 isolates were obtained from
58 pleural tuberculosis patients. Six isolates were from pleural fluid
(SPF-8,24,48,59A,101,103; Table 5) and additional seven isolates
were obtained from the culture of the sputum (SPF-25,
45,59,75A,78,80,85; Table 5) of these TPE patients. Of the 6
samples (2 pleural fluid and 4 sputum samples) which were smear
AFB positive, isolates were obtained from 1 pleural fluid (SPF101)
and 2 sputum samples (SPF-80, 85; Table 5) respectively. Direct
detection and identification of mycobacteria in the sample was
done by the N-PCR in 2 (SPF 85,101, Table 5) of these samples.
The third sample (SPF 80) which was AFB smear and culture
positive was N-PCR negative. This AFB isolate was characterized
as M.chelonae, hence was not detected by the N-PCR assay, which
Table 3. Detection & distribution of mycobacterial pathogens in sputum & pleural fluid samples collected in tandem from 58
clinically suspected tuberculous pleural effusion patients by N-PCR, Culture & AFB smear microscopy.
Total No. of Samples (58) Positive for N-PCR Culture AFB
Both sputum & Pleural Fluid Positive 34.5% (20/58) 0 0
Sputum alone Positive 19.0% (11/58) 12.1% (7/58) p=0.3 6.9% (4/58) p=1.0
Pleural Fluid alone Positive 17.2% (10/58) 10.3% (6/58) p=0.03 3.4% (2/58) p=0.50
Total positivity 70.6% (41/58) p,0.0001 22.4% (13/58) p=0.0005 10.3% (6/58) p=0.038
NOTE. AFB, acid fast bacilli; N-PCR, 116 bp amplicon generated by Nested-PCR assay specific for Mycobacterium tuberculosis; Culture, AFB Growth detected on LJ, 7H9
and/MGIT.
doi:10.1371/journal.pone.0010220.t003
Table 2. Comparative analysis of 70 sputum samples with N-PCR, Culture and AFB with clinical diagnosis.
Method Sputum from tuberculous and non tuberculous patients Sensitivity Specificity & PPV (%) NPV (%) p value
Patients (Tuberculous) (58) Controls (Non- tuberculous) (12)
N-PCR Positive 31 0 53.4 100 30.0 0.0007
Negative 27 12
Culture Positive 7 0 12.1 100 19.0 0.34
Negative 51 12
AFB Positive 4 0 6.9 100 18.1 1.0
Negative 54 12
NOTE. Clinical diagnosis, Categorization of patients and controls as describe in methods; PPV, positive predictive value; NPV, negative predictive value; Sensitivity, TP/
(TP+ FN) x 100, where T is true, F is false, P is positive, and N is negative; Specificity, TN/(TN+ FP) x 100; N-PCR, 116 bp amplicon generated by Nested-PCR assay specific
for Mycobacterium tuberculosis; Culture, AFB Growth detected on LJ, 7H9 and/MGIT; AFB, acid fast bacilli.
doi:10.1371/journal.pone.0010220.t002
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was smear AFB negative but culture AFB positive. The isolate was
N-PCR negative. This isolate was identified as M.fortuitum.N o
mycobacteria were isolated or detected in Non-TPE (Controls).
Comparing the direct identification of Mtb by the N-PCR assay, a
complete concordance was evident in the 13 culture positive
samples, (Table 5). In eleven samples Mycobacterial isolates were
identified by biochemical criteria as Mtb. In all theses samples the
presence of Mtb was directly detected by the N-PCR assay prior to
its isolation and identification.
Discussion
Mycobacterial load is limiting in samples of pleural tuberculosis,
hence its isolation and identification is demanding [16,5]. Direct
examination of pleural fluids by Ziehl-Neelsen staining requires
bacillary densities of 10,000/ml, whereas for isolation by culture
10-100 viable bacilli are needed [17]. Detection of mycobacteria
in suspected cases of pleural effusion has been shown to be
augmented by the inclusion of sputum. Variable sensitivity ranging
from 3.5 to 100% of isolation by culture from sputum collected
from tuberculous pleural effusion patients has been reported,
[18–24]. However in general the isolation of Mtb from pleural fluid
(1.7 to 24.5%) has been lower compared to sputum, [18–20,
22–23,25], with the exception of the reports by Seibert et al &
Epstein et al [21,24]. Similarly the direct AFB smear microscopy of
pleural fluid samples derived from pleural effusion TB patients was
lower (0–20%) as compared to sputum collected from these
patients, [22,25–27]. AFB positivity of sputum smears of pleural
effusion patients ranged from 1.7–62.5% [19,22–23,25].
Besides inclusion of an assortment of samples from an individual
patient, attempts have been made to use rapid reliable DNA
amplification techniques for efficient diagnosis of tuberculosis
[14,23]. The sensitivity of the different PCR assay has been
reported to be ranged from 43.4–73.8% [19,26–29].
In the present study, we have evaluated the (1) inclusion of
sputum along with pleural fluid and (2) the usefulness of the direct
identification and detection of Mtb using an in house N-PCR
assay. It can be seen that the detection of mycobacteria in pleural
fluid and sputum samples varied. Ten pleural fluid samples were
positive, whereas the sputum samples of these patients collected in
tandem were negative. Similarly eleven sputum samples were
positive whereas the pleural fluid samples of these patients were
negative by the N-PCR assay. The inclusion of sputum samples of
clinically diagnosed pleural TB patients increased the total number
of pleural TB patients detected from 30 to 41. The sensitivity of
the assay increased from 51.7 to 70.6%, (Table 1 & 3).
Similarly improvement in AFB microscopy, isolation and
detection of mycobacteria was observed on inclusion of sputum
along with pleural fluid for investigation. Inclusion of sputum
enhanced the sensitivity of AFB smear microscopy from 3.4 to
10.3% and culture sensitivity enhanced from 10.3 to 22.4%,
(Table 1 & 3). The sensitivity of these two classical techniques in
combination with mycobacterial DNA detection techniques would
substantially improve the diagnosis of pleural TB.
Of the 13 isolates obtained in the study, 11 were identified as
Mtb. The remaining two isolates were characterized as
Mycobacterium fortuitum and Mycobacterium chelonae respectively,
(Table 5). There have been reports of these fast growing
mycobacteria being isolated from cases of tuberculous pleurisy
a n de m p y e m a[ 3 0 , 3 1 ] .U s eo fs o l i d&l i q u i dc u l t u r em e d i ai n6 9
patients samples (Pleural fluid & sputum) enhanced sensitivity
from 5.8% (4/69) when using either solid/liquid media alone to
11.6% (8/69) when both solid as well as liquid media were used.
On using automated system (MGIT) the sensitivity observed was
16.1% (5/31), which was higher than the combined efficiency of
LJ and 7H9 media used in the study. Admittedly this sensitivity
observed with the MGIT culture system would have improved
with the inclusion of a solid media such as LJ media, which was
not done.
The results of the N-PCR assay was correlated with clinical
categorization of the patients, AFB smear microscopy and isolation
of Mtb by culture. By the 3 techniques used in the study namely
AFB smear microscopy, culture for mycobacteria and the specific
N-PCR assay for Mtb and Mbo, mycobacteria were detected in
samples exclusively derived from patients clinically diagnosed as
patients of TPE. Comparing the specificity and sensitivity of the 3
techniques it was found that the N-PCR assay had the highest
sensitivity (51.7 to 53.4%) compared to the remaining two
techniques. None of the non-TB pleural fluid samples were
positive by the N-PCR assay, (Table 1 & 2).
Estimation of adenosine deaminase (ADA) and IFN-c in pleural
fluid has been used widely as biochemical markers in the diagnosis
of TB pleural effusion [26,32–33,5]. However these biomarkers
are indicative of an inflammatory process in the pleural cavity and
do not define or identify the aetiological agent. Besides, ADA is
raised in pleural malignancies, lymphoproliferative and rheuma-
toid diseases [34].
The diagnosis of TPE has been considered to be definitive with
the demonstration of Mtb in the examined sample. However the
Table 4. Comparison of N-PCR assay results of samples derived from 58 clinically diagnosed tuberculous pleural effusion patients:
16 AFB positive Vs 42 AFB Negative samples.
S.No
Sample
positive
Results of N-PCR in samples derived from
tuberculous pleural effusion patients Sensitivity (%) PPV (%) NPV (%) OR CI P value
Confirmed
Tuberculous* (16)
Probable
Tuberculous**(42)
1 Pleural Fluid alone 2 8 12.5 20.0 70.8 0.60 0.11–3.2 ns
2 Sputum alone 4 7 25.0 36.3 74.4 1.66 0.41–6.71 ns
3 Both positive 8 12 50.0 40.0 78.9 2.5 0.76–8.1 ns
4 Any one/both 14 27 87.5 34.1 88.2 3.88 0.7–19.4 ns
NOTE. PPV, positive predictive value; NPV, negative predictive value; OR, odds ratio; CI, confidence interval.
*Categorized based on detection of AFB by smear microscopy/isolation by culture.
**Categorized based on clinical criteria detailed in methods, but no AFB detected smear microscopy/isolation by culture.
ns = not significant.
doi:10.1371/journal.pone.0010220.t004
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from samples of pleural effusion and the limited sensitivity of the
techniques employed have hampered the diagnosis of TPE.
Further, histolopathological examination of pleural biopsies for
granulomatous inflammation consistent with tuberculosis has been
reported to be more sensitive than pleural fluid culture [18,26,20].
Pleural fluid has been reported to be a poor source of
mycobacteria [19]. Several investigators have reported that pleural
biopsies to be the most reliable for diagnosis of TPE provided the
appropriate site is available for examination [35,25]. However, the
invasiveness of the procedure, inability to obtain characteristic
pleural tissue and the accompanied complications has been the
limitations in this regard. In the present study irrespective of the
technique used qualitative improvement in the detection of
mycobacteria in TPE derived samples, was seen with the inclusion
of sputum samples.
In conclusion, detection of Mycobacteria either by microscopy/
classical microbiological techniques or by DNA amplification
techniques in pleural effusion patients was enhanced by examining
pleural fluid as well as sputum collected in tandem. Further
comparing the three methods, Mycobacterium tuberculosis was
detected by the N-PCR assay in 70.6% of the samples compared
to 22.4% by culture and 10.3% by AFB smear microscopy. This
improvement by molecular methods in identification of pathogens
can be sustained by targeting appropriate gene targets and
adopting sensitive detection techniques.
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